Human 8-OHdG(DNA Damage) ELISA Kit – 48 tests

Ref.: BL-RE-996177Manufacturer ref.: ELK10908-48T 48 tests
€363.00 excl. VAT

Human 8-OHdG(DNA Damage) ELISA Kit, 48 tests. For research use only.

Format
48 tests (1 plate of 48 wells)
Species
Human
Target
8-OHdG (DNA Damage)
Type of dosage
ELISA by competition
Sensitivity
0.59 ng/mL
Brand
ELK Biotechnology

ELISA quantitative assay by human 8-OHdG competition (serum, plasma, other biological fluids), 2 h.

This ELISA ELK Biotechnology kit allows in vitro quantitative assays of human 8-OHdG (DNA Damage) in the following samples: serum, plasma and other biological fluids.

The assay is based on ELISA by competition: the microtitration plate is pre-coatted with the target antigen. Standards or samples are added with a specific biotinylated antibody, then l-avidine coupled with peroxidase (HRP). After addition of the TMB substrate, the colour intensity, measured at 450 nm ± 10 nm, is inversely proportional to the concentration of 8-OHdG.

Research-only product (RUO), not intended for diagnosis.

Sensitivity

Sensitivity of 0.59 ng/mL.

Range of dosage

The range of dosages from 1.56 to 100 ng/mL (highest standard: 100 ng/mL).

Samples

Serum, plasma and other biological fluids.

Rapidity

Result in 2 hours.

Specificity

Format by competition, specific antibodies of human 8-OHdG.

Reproducibility

Intra-test accuracy CV < 8%, inter-test CV < 10%.

Technical specifications

General
BrandELK Biotechnology
RangeStandard
Specifications
Format48 tests (1 plate of 48 wells)
SpeciesHuman
Target8-OHdG (DNA Damage)
Type of dosageELISA by competition
Performance
Sensitivity0.59 ng/mL
Range of dosage1.56 – 100 ng/mL
Standard (maximum concentration)100 ng/mL
Duration of dosing2 h
Readability wave length450 nm ± 10 nm
Specifications
SamplesSerum, plasma and other biological fluids
Research areaMetabolic routes, Antitumour immunity, Anti-infectious immunity, Endocrinology, Hematology, Hepatitis
Alternative names8OHdG; 7.8-Dihydro-8-Oxo-2'-Deoxyguanosine; 7.8-Dihydro-8-Oxodeoxyguanosine; 8-Hydroxy-2'-Deoxyguanosine; 8-Oxo-DG; 8-Hydroxydeoxyguanosine
Storage and shipping
ShippingWith ice loaves, without carboglace
Compliance
Useresearch use only (RUO)
Validation
Intra-test accuracyCV < 8 %
Inter-test accuracyCV < 10 %
Standard curve (example)100.00 ng/mL : DO 0.191; 0.367 ng/mL : DO 25.00; 12.50 ng/mL : DO 0.861; 1.157 ng/mL : DO 3.13; 1.57 ng/mL : DO 1.775
Recovery (doped samples)serum (n=5): 95-107% (average 101%); EDTA plasma (n=5): 80-93% (average 86%); heparin plasma (n=5): 94-105% (average 87%)
Linearity (dilutions)serum (n=5): 1:2 92-101%, 1:4 87-98%, 1:8 85-94%, 1:16 87-101%; EDTA plasma (n=5): 1:2 86-94%, 1:4 93-102%, 1:8 87-96%, 1:16 92-105%; heparin plasma (n=5): 1:2 88-102%, 1:4 87-101%, 1:8 85-95%, 1:16 85-96%
Conservation
Storage of kitKit not open: 2-8 °C for 6 months, or -20 °C for 1 year; avoid freeze-thaw cycles.
Safety data sheetDownloadable with a B-LABO account

Origin and customs

Manufacturer ref.ELK10908-48T
Country of originChina
HS customs code3822 19 00 00

Scope of delivery

  • Pre-coated microplate: 6 strips × 8 wells (conservation 4 °C or -20 °C)
  • Standard lyophilized: 1 vial (storage 4 °C or -20 °C)
  • Biotinylated -Conjugate (100×): 30 μL (storage 4 °C or -20 °C)
  • Streptavidine-HRP (100×): 60 μL (storage 4 °C or -20 °C)
  • Standard dilution stamp/samples: 10 mL (storage 4 °C or -20 °C)
  • Biotinylated -Diluent conjugate: 5 mL (storage 4 °C or -20 °C)
  • HRP diluent: 6 mL (storage 4 °C or -20 °C)
  • Wash pad (25×): 10 mL (storage 4°C or -20°C)
  • TMB substrate solution: 6 mL (storage 4 °C or -20 °C (in the shelter of light))
  • Stopping solution: 3 mL (storage 4 °C or -20 °C)
  • Adhesive film for plate: 1 piece (storage of room temperature)

Documentation

Manufacturer SDS (ELK Biotechnology). Free download after signing in or creating an account.
Customers who have ordered: the SDS is attached automatically to the order confirmation.
A question or a specific configuration?
Contact us for a quote.